Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Therapeutics|June 6, 2006
A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or kneeAlan Kivitz, Carl Ma, Harry Ahdieh, et al.Archives of Physical Medicine and Rehabilitation|December 14, 2005
Efficacy and safety of oxymorphone immediate release for the treatment of mild to moderate pain after ambulatory orthopedic surgery: results of a randomized, double-blind, placebo-controlled trialJoseph S Gimbel, Dean Walker, Tina Ma, et al.Journal of Clinical Pharmacology|February 11, 2005
Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathwaysMichael Adams, Henry J Pieniaszek, Arnold R Gammaitoni, et al.Journal of Opioid Management|July 21, 2010
Long-term tolerability and effectiveness of oxymorphone extended release in patients with cancerNeal E Slatkin, Michelle I Rhiner, Errol M Gould, et al.Clinical Therapeutics|August 19, 2007
Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trialKeith Aqua, Joseph S Gimbel, Neil Singla, et al.Current Medical Research and Opinion|January 30, 2007
A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back painNathaniel Katz, Richard Rauck, Harry Ahdieh, et al.Pain|July 10, 2012
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendationsDennis C Turk, Alec B O'Connor, Robert H Dworkin, et al.Pageof 2